Immunicum (Sweden)

Recent papers from Immunicum (Sweden)

1. T Cell O‐ GlcNAcylation Increases in Patients With Allergic Rhinitis After the Natural Pollen SeasonClinical & Experimental Allergy · 2026
2. Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 StudyEuropean Urology Open Science · 2022
3. High‐dose pollen intralymphatic immunotherapy: Two RDBPC trials question the benefit of dose increaseAllergy · 2021
4. High dose pollen intralymphatic immunotherapy: two RDBPC trials question the benefit of dose increase2021
5. ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patientsEuropean Journal of Cancer · 2020
6. Phase 1 Trial With the Cell-Based Immune Primer Ilixadencel, Alone, and Combined With Sorafenib, in Advanced Hepatocellular CarcinomaFrontiers in Oncology · 2019
7. Ilixadencel – an Allogeneic Cell-Based Anticancer Immune Primer for Intratumoral AdministrationPharmaceutical Research · 2018
8. Cancer vaccine based on a combination of an infection-enhanced adenoviral vector and pro-inflammatory allogeneic DCs leads to sustained antigen-specific immune responses in three melanoma modelsOncoImmunology · 2017
9. Pro-inflammatory allogeneic DCs promote activation of bystander immune cells and thereby license antigen-specific T-cell responsesOncoImmunology · 2017
10. Intratumorally injected pro-inflammatory allogeneic dendritic cells as immune enhancers: a first-in-human study in unfavourable risk patients with metastatic renal cell carcinomaJournal for ImmunoTherapy of Cancer · 2017